THERAPEUTIC VEGETABLE SUBSTANCES

摘要

A pharmaceutical product containing papain, bromelain or mixtures thereof is intended for the treatment of several pathologies, such as Alzheimer's disease and depression, at a dosage of at least 7000 mg administered in a single dose. This dosage relates to papain powder having a titre of 3 U/mg and bromelain powder having a titre of 2 U/mg, and to a patient with a body weight of 55 kg. In the case of variations of the titre and/or of the body weight of the patient, the dosage must be adjusted in proportion to said variations.

主权项

1. A therapeutic method for treating Alzheimer's disease, comprising administering to a mammal in need thereof a product containing papain, bromelain or mixtures thereof at a dosage of at least 7000 mg delivered for at least 30 consecutive days in a single daily dose, said dosage being referred to a papain powder having a titer of 3 U/mg and a bromelain powder having a titer of 2 U/mg, as well as to a patient with a body weight of 55 kg, wherein in case of variations of the titer and/or the body weight of the patient the dosage must be adjusted in proportion to said variation.